Scout Bio is a biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. The Company is advancing a number of programs across chronic kidney disease, chronic pain, and the inflammatory skin condition atopic dermatitis. Scout Bio's approach is to deliver a long-term expression of therapeutic proteins in pet patients using adeno-associated viral (AAV) vector technology, administered through a single intramuscular injection.